India-China MoU aims to improve market access for drugs
This article was originally published in SRA
Executive Summary
India is seeking faster and expanded access to the Chinese pharmaceutical market as the two Asian giants aim for an overall bilateral trade target of $100 billion by 20151. Plans to expand trade across sectors between the two countries were announced as part of the state visit to India of Chinese premier Li Keqiang.